The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical products, authorized, on 16

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Thursday, February 6, 2025, at 9:00 a.m. ET, to discuss its 2024 Fourth-Quarter and Full-Year financial results,

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.

Zyn is manufactured by Swedish Match, which Philip Morris International acquired in a $16 billion deal in 2022. That year, Zyn shipped 238 million cans in the U.S. Philip Morris International forecasts that the total more than doubled in 2024. Zyn's growth comes as the company looks to transition more to smokeless products.

The Food and Drug Administration has ignited a heated debate with its latest review of menthol cigarettes, revealing concerning patterns that could lead to

On January 16, Philip Morris International Inc. (NYSE:PM) announced that the US Food and Drug Administration (FDA) has authorized all ZYN nicotine pouches currently marketed by Swedish Match.

Yet Altria still leads the cigarette market by a wide margin, its profits are solid, and its dividend that yields 8% annually remains secure. Having raised the payout for 55 consecutive years, should investors add this Dividend King to their portfolio?

BofA Securities made an adjustment to the price target for Altria stock, bringing it down to $61 from the previous $65, while still maintaining a Buy rating on the shares. This change was announced by BofA Securities analyst Lisa Lewandowski,

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with certain patient monitors from Contec and Epsimed and urged healthcare facilities to mitigate those risks.

TABAK.PR Philip Morris CR a.s.

$ 122.3422-1.4678-1.19%

MEAG Munich Ergo, a Munich Re company, slashed stakes in Philip Morris, Apple, and PayPal, and bought Lululemon stock in the fourth quarter.